These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10937722)

  • 1. Antitumor promoting activities of 3-O-acyl-(-)epigallocatechins.
    Uesato S; Kitagawa Y; Hara Y; Tokuda H; Okuda M; Mou XY; Mukainaka T; Nishino H
    Bioorg Med Chem Lett; 2000 Aug; 10(15):1673-5. PubMed ID: 10937722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of 6-O-acylated L-ascorbic acids possessing a straight- or branched-acyl chain on Epstein-Barr virus activation.
    Uesato S; Kitagawa Y; Kaijima T; Tokuda H; Okuda M; Mou XY; Mukainaka T; Nishino H
    Cancer Lett; 2001 May; 166(2):143-6. PubMed ID: 11311486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of 3-O-acyl-(+)-catechins on Epstein-Barr virus activation.
    Uesato S; Taniuchi K; Kumagai A; Nagaoka Y; Seto R; Hara Y; Tokuda H; Nishino H
    Chem Pharm Bull (Tokyo); 2003 Dec; 51(12):1448-50. PubMed ID: 14646330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of monoacylated 2-O-beta-galactosylglycerols on Epstein-Barr virus activation: the significant role of the hexanoyl chain.
    Colombo D; Compostella F; Ronchetti F; Scala A; Toma L; Mukainaka T; Nagatsu A; Konoshima T; Tokuda H; Nishino H
    Cancer Lett; 1999 Aug; 143(1):1-4. PubMed ID: 10465330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor chemopreventive activity of 3-O-acylated (--)-epigallocatechins.
    Kumagai A; Nagaoka Y; Obayashi T; Terashima Y; Tokuda H; Hara Y; Mukainaka T; Nishino H; Kuwajima H; Uesato S
    Bioorg Med Chem; 2003 Nov; 11(23):5143-8. PubMed ID: 14604677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic and branched acyl chain galactoglycerolipids and their effect on anti-tumor-promoting activity.
    Colombo D; Franchini L; Toma L; Ronchetti F; Tanaka R; Takayasu J; Nishino H; Tokuda H
    Eur J Med Chem; 2006 Dec; 41(12):1456-63. PubMed ID: 16996658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on inhibitors of skin tumor promotion. XI. Inhibitory effects of flavonoids from Scutellaria baicalensis on Epstein-Barr virus activation and their anti-tumor-promoting activities.
    Konoshima T; Kokumai M; Kozuka M; Iinuma M; Mizuno M; Tanaka T; Tokuda H; Nishino H; Iwashima A
    Chem Pharm Bull (Tokyo); 1992 Feb; 40(2):531-3. PubMed ID: 1318792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of stabilized analogues of glycoglycerolipids on Epstein-Barr virus activation and mouse skin tumor promotion.
    Colombo D; Compostella F; Ronchetti F; Reza-Elahi S; Scala A; Toma L; Aoi W; Kuchide M; Takayasu J; Tokuda H; Nishino H
    Cancer Lett; 2002 Dec; 186(1):37-41. PubMed ID: 12183073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of Epstein-Barr virus activation by Citrus fruits, a cancer chemopreventor.
    Iwase Y; Takemura Y; Ju-ichi M; Kawaii S; Yano M; Okuda Y; Mukainaka T; Tsuruta A; Okuda M; Takayasu J; Tokuda H; Nishino H
    Cancer Lett; 1999 May; 139(2):227-36. PubMed ID: 10395183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationship in potentially anti-tumor promoting benzalacetone derivatives, as assayed by the epstein-barr virus early antigen activation.
    Motohashi N; Yamagami C; Tokuda H; Okuda Y; Ichiishi E; Mukainaka T; Nishino H; Saito Y
    Mutat Res; 2000 Jan; 464(2):247-54. PubMed ID: 10648911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves ERK1/2 and PI3-K/Akt signaling in EBV-positive cells.
    Liu S; Li H; Chen L; Yang L; Li L; Tao Y; Li W; Li Z; Liu H; Tang M; Bode AM; Dong Z; Cao Y
    Carcinogenesis; 2013 Mar; 34(3):627-37. PubMed ID: 23180656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of tissue cultures and thalli of lichens and some of their active constituents for inhibition of tumor promoter-induced Epstein-Barr virus activation.
    Yamamoto Y; Miura Y; Kinoshita Y; Higuchi M; Yamada Y; Murakami A; Ohigashi H; Koshimizu K
    Chem Pharm Bull (Tokyo); 1995 Aug; 43(8):1388-90. PubMed ID: 7553984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects on Epstein-Barr virus activation of anthraquinones: correlation with redox potentials.
    Koyama J; Tagahara K; Osakai T; Tsujino Y; Tsurumi S; Nishino H; Tokuda H
    Cancer Lett; 1997 May; 115(2):179-83. PubMed ID: 9149122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of dihydroagarofuran sesquiterpenes on Epstein-Barr virus activation.
    Takaishi Y; Ujita K; Tokuda H; Nishino H; Iwashima A; Fujita T
    Cancer Lett; 1992 Jul; 65(1):19-26. PubMed ID: 1324784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of cucurbitane triterpenoids on Epstein-Barr virus activation and two-stage carcinogenesis of skin tumors.
    Konoshima T; Takasaki M; Tatsumoto T; Kozuka M; Kasai R; Tanaka O; Nie RL; Tokuda H; Nishino H; Iwashima A
    Biol Pharm Bull; 1994 May; 17(5):668-71. PubMed ID: 7920430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced Epstein-Barr virus early antigen activation by natural colorants.
    Kapadia GJ; Balasubramanian V; Tokuda H; Iwashima A; Nishino H
    Cancer Lett; 1997 May; 115(2):173-8. PubMed ID: 9149121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor-promoting effects of 8-substituted 7-methoxycoumarins on Epstein-Barr virus activation assay.
    Ito C; Itoigawa M; Furukawa H; Tokuda H; Okuda Y; Mukainaka T; Okuda M; Nishino H
    Cancer Lett; 1999 Apr; 138(1-2):87-92. PubMed ID: 10378778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer chemopreventive agents, 4-phenylcoumarins from Calophyllum inophyllum.
    Itoigawa M; Ito C; Tan HT; Kuchide M; Tokuda H; Nishino H; Furukawa H
    Cancer Lett; 2001 Aug; 169(1):15-9. PubMed ID: 11410320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanthones as inhibitors of Epstein-Barr virus activation.
    Ito C; Itoigawa M; Furukawa H; Rao KS; Enjo F; Bu P; Takayasu J; Tokuda H; Nishino H
    Cancer Lett; 1998 Oct; 132(1-2):113-7. PubMed ID: 10397461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoglycerolipid analogues active as anti-tumor-promoters: the influence of the anomeric configuration.
    Colombo D; Compostella F; Ronchetti F; Scala A; Toma L; Tokuda H; Nishino H
    Eur J Med Chem; 2000 Dec; 35(12):1109-13. PubMed ID: 11248409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.